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Abstract: Flavan-3-ols are involved in multiple metabolic pathways that induce inhibition 
of cell proliferation. We studied the structure-activity relationship of gallic acid (GA) and 
four flavan-3-ols: epigallocatechin gallate (EGCG), epigallocatechin (EGC), catechin (C), 
and epicatechin (EC). We measured the cell viability by the MTT assay and we determined 
the concentration of testing compound required to reduce cell viability by 50% (IC50). All 
tested compounds showed a dose-dependent and time-dependent inhibitory antiproliferative 
effect on Hs578T cells; IC50 values varying from the 15.81 to 326.8 µM. Intracellular ROS 
(reactive oxygen species) were quantified using a fluorescent probe 2’,7’-dichlorofluorescin 
diacetate (DCFH-DA). Only the treatment with 10 µM EGC and EGCG was able to induce 
a significant decrease of ROS concentration and increased levels of ROS were registered 
for 100 µM EGCG, EGC and GA. Flavans-3-ols and GA induced apoptosis in a dose- and 
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time-dependent manner, which indicated that the induction of apoptosis mediated  their 
cytotoxic activity  at least partially. The galloylated catechins have shown a  stronger 
antiproliferative activity and apoptotic effect than the one produced by  non galloylated 
catechins. The galloylated flavan-3-ols are potential therapeutic agents for patients with 
triple negative breast cancer via induction of apoptosis. 
Keywords:  catechins;  structure-activity relationship;  gallate moiety;  cell proliferation; 
apoptosis; pro/antioxidant 
 
1. Introduction  
The class of natural compounds with biological active properties such as polyphenols has attracted 
attention in terms of beneficial effects on human health, due to their low toxicity, low cost and high 
availability. Catechins and catechin gallates belong to the class of polyphenol compounds, subclass  
of flavan-3-ols, which include (−)-epigallocatechin-3-gallate  (EGCG),  (−)-epigallocatechin (EGC), 
(−)-epicatechin (EC), (+)-catechins (C) and (−)-epicatechin-3-gallate (ECG). EGCG and ECG contain 
a gallic acid moiety at position 3 on the C ring (Figure 1) [1–7].  
Figure 1. Chemical structure of catechins and gallic acid (GA); the gallate moiety is circled.  
 
Flavan-3-ols are characterized by hydroxylated aromatic rings. They are 3-ring phenolic compounds 
with a double ring attached by a single bond to a third ring and they have multiple hydroxyl groups  
on the A, B and C rings. The heterocyclic benzopyran ring is known as the C ring, the fused aromatic 
ring as the A ring, and the phenyl constituent as the B ring. The A ring can be of two types: a Int. J. Mol. Sci. 2011, 12                    
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phloroglucinol type that is meta-trihydroxylated, or a resorcinol type that is meta-dihydroxylated. The 
B ring can be monohydroxylated, ortho-dihydroxylated or vicinal-trihydroxylated [1–4]. The catechin 
and epicatechin are epimers. The structural difference between EGC and EC is an additional hydroxyl 
group at 5’ position of the B ring for EGC. EGCG is an EGC ester derivative, resulting from an 
esterification at 3 hydroxyl position of the C ring with a gallate moiety [2,3]. 
Flavan-3-ols  present  antioxidant activity in cell-free systems, both  in vitro  and  in vivo.  Many 
mechanisms of action for the flavan-3-ols chemopreventive activities have been proposed [2,4–12]. 
One of these mechanisms is their pro/antioxidant activity. The antioxidant capacity of flavan-3-ols is 
proved particularly by their abilities to upregulate antioxidant enzymes and to scavenge the reactive 
oxygen species (ROS) [2,6].  
Flavan-3-ols and their derivatives are a class of phenolic compounds found in green tea leaves, 
chocolate, grape and grape seeds, having several healthy properties. An anticarcinogenic activity and a 
protective capacity against oxidative stress-related diseases were previously described [2,3,10]. Several 
flavan-3-ols have been reported as apoptosis inducers and inhibitors of cell proliferation in human 
tumor cells [2,4]. In addition, recent studies indicated their involvement in the modulation of signal 
transduction pathways, cell survival/death, mitochondrial function and angiogenesis [2–4,6–12].  
Most studies have evaluated the biological active properties of EGCG, and only few focused on the 
relation between the  chemical structure and the  antiproliferative or anti/prooxidant proprieties of 
flavan-3-ols, with or without gallate moiety. The development of structure-activity relationships may 
facilitate the research on cancer therapy. In the present study, we addressed the relation between gallic 
acid (GA) and flavan-3-ols structures and their activity in Hs579T cell line, an in vitro system for 
highly invasive triple negative human breast cancer  [3].  We determined the cell viability and the 
concentration of each compound required to reduce cell viability by 50% (IC50). The putative 
antiapoptotic and anti/prooxidant properties were investigated in order to evaluate a possible relation 
between structure and activity of flavan-3-ols and GA. 
2. Results and Discussion  
2.1. The Antiproliferative Effect of Flavan-3-Ols and GA 
At first, we investigated the effect of GA and four types of flavan-3-ols on cultured Hs578T cells. The 
cells were incubated with the selected compounds, at concentrations between 0–750 µM (Figure 2). The 
MTT values after 24, 48 and 72 h incubation are represented as % of control, in relation with the log 
(concentration, µM) (Figure 2). From these plots, IC50, as well as other statistical parameters, were 
determined using GraphPad Prism free-trial software (Table 1). The results are presented in Figure 2 
and Table 1.  A difference of the  antiproliferative effect based on the measurement of IC50  was 
observed in the case of cellular treatment and was ranked as follows: EGCG > ECG > EC > GA > C as 
shows 24 hours’ results. 
The concentration of GA required to reduce Hs578T cell viability by 50% (IC50) was 211.1 µM at 
24 h, 40.14 µM at 48 h, and 31.76 µM at 72 h. These results emphasize the fact that gallate moiety is a 
key component of the antiproliferative effect of tested catechins, by comparing their IC50. The highest Int. J. Mol. Sci. 2011, 12                    
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antiproliferative effect was observed in the case of EGCG, IC50 of 131.6 µM at 24 h, 15.8 µM at 48 h, 
and 17.75 µM at 72 h; C was less efficient. 
Our data showed that all compounds tested exert a dose and time-dependent antiproliferative effect 
on Hs578T cells. However, we found a differential effect for each compound, with IC50 values varying 
from the 15.81 to 326.8 µM. Among the structurally related catechins, the EGCG was the most 
powerful in inhibiting the growth of breast cancer cells.  
Figure 2. The antiproliferative effect as measured by MTT assay after 24, 48 and 72 h, in 
incubation with different concentrations (0–750 µM) of flavan-3-ols or GA on Hs578T cell 
line; log (conc, µM) = log[concentration of bioactive compound, µM] (mean ± SD, n = 6). 
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Table 1. IC50 values determined by the MTT test after 24, 48 and 72 h of treatment on 
Hs578T cell line. 
Time (h)  Compound  IC50 (µM)  Slope  R2 
24  EGCG  131.6  −1.086  0.9522 
ECG  155.1  −0.7287  0.9601 
EC  180.4  −0.7303  0.7820 
C  326.8  −0.4809  0.6794 
GA  211.1  −0.7720  0.9016 
48  EGCG  15.8  −0.3760  0.6944 
EGC  43.49  −0.7227  0.5283 
EC  89.59  −1.220  0.9251 
C  250.0  −1.233  0.9324 
GA  40.14  −1.002  0.9424 
72  EGCG  17.75  −0.9903  0.9509 
ECG  32.56  −0.7985  0.9446 
EC  67.45  −0.5975  0.8716 
C  233  −1.205  0.9136 
GA  31.67  −1.270  0.9394 
Several studies have evaluated the antiproliferative effect of EGCG, but the other flavan-3-ols 
with/without gallate moiety received less scientific attention. The present study shows that the gallate 
moiety is a key component. The EGCG contains two gallate moieties, which could explain the highest 
antiproliferative effect observed in the present study. 
After 48 h cell treatment with flavan-3-ols and GA, the MTT values obtained were lower than those 
observed at 24 h and relatively similar to those registered at 72 h. These results could be explained by 
their transformation into new metabolic products that induce a higher antiproliferative activity as 
opposed to the untransformed compound. A similar study [7] demonstrated that some tested phenolic 
acids exert a dose and time-dependent inhibitory antiproliferative effect on T47D breast cancer cells. 
Nevertheless, they found a differential effect for each phenolic acid, with IC50 values varying between 
nanomolar and picomolar range [6]. In our study, the flavan-3-ols show various IC50 values, within  
the µM range.  
Similar differential growth inhibitions were also observed between the human colorectal cancer cell 
line (Caco-2) and Hs578T, but not in their respective normal counterparts [8]. The proliferation and/or 
viability of cultured Hs578T and MDA-MB-231 estrogen receptor-negative breast cancer cell lines 
was proved to be reduced by EGCG treatment in a similar study. Similar negative effects on 
proliferation were observed with the DMBA-transformed D3-1 cell line. In 1998, Chen et al. evaluated 
the antiproliferation ability of EGCG in HT-29 cancer cell line. In this study, EGCG inhibited cell 
proliferation in a dose-dependent manner [6,8]. After 36 h treatment, EGCG inhibited HT-29 cell 
growth with an IC50 of approximately 100 µM [7]. From Figure 2, it can be observed that the EGCG 
have the best antiproliferative action at all intervals of time evaluated. The IC50 values for EGCG at 
24 h are in agreement with Chen et al., 1998, but at 48 h they are much lower.  
The difference between EGCG on one side and the C and EGC on the other side is determined by 
the gallate group; we can suppose that at 24 h the EGCG treated cells have the best antiproliferative Int. J. Mol. Sci. 2011, 12                    
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activity due to this gallate. The structural differences in flavan-3-ols might explain the differences  
in the antiproliferative responses. At 48  h, EGCG and other catechins maintained their highest 
antiproliferative effects with the highest values than those observed at 24 h. Thus, we can assume that 
after 24 h, the flavan-3-ols were oxidized and the metabolic products were more efficient. This may 
prove their pro/antioxidant properties [8].  
2.2. Apoptotic Effects of Flavan-3-Ols and GA 
The MTT results showed a reduction in cell proliferation, which might be due to an increase in the 
apoptotic processes. Thus,  we measured the apoptosis rate of Hs578T cells exposed to increasing 
concentrations of different flavan-3-ols (Figure 3). 
Figure 3. Apoptosis evaluation in Hs578T cells after treatment with flavan-3-ols and GA. 
The cells were stained with Calcein AM and Annexin-Cy5 and were evaluated using the 
Cell Fluorescence LabChip kit for 2100 bioanalyzer and  the  results expressed at % of 
apoptotic cells at 24 h and 48 h. 
 
Cell apoptosis was induced by flavan-3-ols treatment as shown by the flow cytometry (Figure 3). 
Apoptosis may be induced directly by flavan-3-ols or indirectly by their metabolic products [9]. Our 
data suggest that the hydroxyl groups on the phenolic ring are essential for the antiproliferative and 
apoptotic activity. The phenolic hydroxyl groups of catechins are primarily responsible for scavenging 
free radicals, whereas the galloyl moiety is involved in chelating metal ions [10]. The present study 
revealed a potentially important role of the galloyl structure in the antiproliferative and proapoptotic 
responses, when comparing the results obtained for GA with those for the flavan-3-ols. 
The intrinsic capacity of catechins to form quinone type metabolites upon their oxidation was 
demonstrated in a recent study [12]. The formation of quinone type metabolites, especially involving 
the pyrogallol moiety of these catechins [11], can induce the antiproliferative effect,  leading to 
apoptosis.  The pyrogallol-type structure  plays an important role in the induction of  
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apoptosis [10,13,14]. These results reveal the fact that flavan-3-ols, such as C and EC lacking the 
gallate structure, with only catechol and/or resorcinol groups, are less efficient in inducing apoptosis. 
The GA induced apoptotic cell death in human promyelocytic leukemia HL-60 cells. The effect of 
GA was significantly reduced by blocking ROS [15]. This study suggests the prooxidant action of GA 
in the induction of apoptosis and confirms our data. On the other hand, the addition of larger alkyl 
groups to the carboxyl group of GA did not increase the ROS either, but significantly increased its 
apoptosis-inducing activity. Other studies suggested that the capacity to induce apoptosis involves the 
extracellular production of ROS [16]. This may be due to the increased lipophilicity of the gallate 
molecule—a factor that induces apoptosis through a yet unknown mechanism [14,15,17].  
2.3. Detection of Intracellular ROS 
Our unpublished data confirm that the ROS show a steady increase of the fluorescence intensity 
even in the control group, suggesting that ROS are formed spontaneously in the Hs578T cell line, the 
maximum fluorescence intensity being registered at 3 h. The effects of two concentrations (10 and 
100 µM) of flavan-3-ols and GA at 3 h after treatment are presented in Figure 4. Only the treatment with 
10 µM EGC and EGCG was able to induce a significant decrease (p < 0.05) of ROS concentration as 
compared to the control group and an increased level (p < 0.05) of ROS, as compared to the control 
group, for 100 µM EGCG, EGC and GA.  
Figure 4. Effect of flavan-3-ols (10 and 100 µM) at 3 h after treatment on evaluation 
reactive oxygen species (ROS)  as measured by DCFH-DA fluorescence intensity on 
Hs578T cells. 
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Generally, the health promoting activities of catechins, including the antiproliferative effect, are 
mainly attributed to their  antioxidant  capacity and  ability to scavenge ROS [18].  The antioxidant 
effects have been proven on several cellular and molecular targets associated with cell death and cell 
survival [2–4,18]. These properties are due to the presence of the phenolic hydroxy groups on the B 
ring in ungalloylated catechins (EC and EGC) (Figure 1) and on the B and D rings of the galloylated 
catechins (ECG and EGCG). The presence of the 3,4,5-trihydroxy B ring has been shown to be Int. J. Mol. Sci. 2011, 12                    
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significant for the antioxidant and radical scavenging activities, and the order of their effectiveness 
beeing EGCG > EGC > EC > C. 
Flavan-3-ols are highly hydrophilic molecules and there are supposed to act as antioxidants in  
the aqueous compartment [19]. Antioxidant activity of EGCG at physiological  concentrations  
(0.1–1 μM) [20], underline the interdependency between the scavenging of radicals in the hydrophilic 
and hydrophobic environments [21]. Thus, it is suggested that the presence of the gallate group at the  
3 position plays the most important role in their free radical-scavenging abilities and an additional 
insertion of a hydroxyl group at the 5’ position in the B ring also contributes to their scavenging 
activities [20,22]. 
Specific structural components in catechins are reported to be responsible for the different biologic 
activities, including ROS, as the present study shows [2]. This is confirmed by the present study for all 
tested compounds at a concentration of 10 µM. Literature data suggest that the number of hydroxyl 
groups on the B ring contributes significantly to the ROS scavenging of flavan-3-ols [14]. Recently, 
the view has changed, and flavonoids are  now  thought to act as direct antioxidants but rather  as 
inhibitors of prooxidant enzymes or as chelators of transition metals that mask prooxidant actions of 
reactive nitrogen species (NOS) and ROS [23]. 
The hydroxyl groups from the three different rings also enhance the inhibition of ROS or induce  
the prooxidant effect,  as it is for EGC and GA. This may be explained by  the  presence of the   
ortho-trihydroxyl group in the B ring, which is important for scavenging super-oxide anion, whereas 
the galloyl moiety is responsible for quenching the hydroxyl radicals [24]. Also,  the conjugation 
between A, B and C rings may provide a resonance effect in the aromatic nucleus that may 
differentially stabilize the phenoxyl radicals of the different flavan-3-ols structures [14,25,26]. The 
phenoxyl radicals formed during oxidation are quite stable at higher pH [26].  
A large number of studies indicate that tea catechins can act as prooxidants [27,28]. These prooxidant 
effects are observed under in vitro conditions at pharmacological dose [29]. However, it is still unclear 
whether the effects exerted on molecular endpoints in signal transduction pathways are downstream 
events of the modulation of pro/antioxidant balance in cells or they are due to the direct action of 
EGCG and other catechins on the various molecular targets, independently of the antioxidant activities. 
Furthermore, most of the putative molecular mechanisms that have been proposed are based on in vitro 
studies at far higher EGCG concentrations than those achievable in vivo. It has been established that 
the B ring, hydroxyl group and galloyl moiety of the catechins are the main contributing factors to 
their scavenging activities and the presence of the ortho-dihydroxyl group in the B ring and the galloyl 
moiety are important in maintaining the effectiveness of the radical scavenging ability [29].  Our 
previous studies have shown that physiologically achievable concentrations of flavan-3-ols protect the 
cells from ROS induction by mycotoxins [14, 29].  
3. Experimental Section  
3.1. Cell Culture 
HS578T cells (ECACC) have been grown at 37 °C in a humidified atmosphere with 5% CO2 in 
Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich, Germany), with 4500 mg/L glucose, Int. J. Mol. Sci. 2011, 12                    
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supplemented with 10% fetal bovine serum, without sodium pyruvate, 2 mM L-glutamine, 100 U/mL 
penicillin and 100 U/mL streptomycin, 10 µg/mL insuline (Actrapid, Novo Nordisk, Denmark). 
3.2. Cell Treatment 
Cells were treated for 24, 48 and 72 h, with different concentrations (1, 5 10, 25, 100, 250, 750 µM) 
of flavan-3-ols (EGCG, ECG, C, EC) or GA, for the evaluation of cell viability by using the MTT test. 
All reagents were purchased from Sigma-Aldrich. The evaluation of apoptosis was done at 24 and 48 h 
after treatment, with 10 and 100 µM of the selected compounds. 
3.3. MTT Assay 
2 × 10
4 Hs578T cells were treated with flavan-3-ols in a 98-well plate, as described above and 
incubated for 24, 48 and 72 h, respectively. In order to perform the MTT assay, the culture medium 
was removed; cells were washed with PBS and 150 μL Hanks salt containing MTT (Sigma-Aldrich, 
Germany). A  final  concentration of 455 μg MTT/mL Hanks  salt was added  into each well.  After  
2 hour-incubation under standard conditions, the MTT solution was removed and 200 μL of DMSO 
were added into each well. The absorbance was measured at 490 nm using a Biotek Synergy HT 
Microplate Plate Reader.  
3.4. Detection of Intracellular ROS 
Intracellular ROS were quantified by using a fluorescent probe 2’7’-  dichlorofluorescin diacetate 
(DCFH-DA). The DCFH-DA diffuses  quickly through the  cell membrane and it is enzymatically 
hydrolyzed by intracellular esterases to non-fluorescent dichlorofluorescin-diacetate (DCFHDA), which 
is rapidly oxidized to highly fluorescent dichlorofluorescin (DCF) in the presence of intracellular reactive 
oxygen species. Cells were seeded in 96-well black plates, 2 × 10
3 cells per well, and allowed to grow for 
24 h. After that, the cells were treated with various concentrations of flavan-3-ols and of DCFH-DA 
(final concentration 0.1 µM). The DCF fluorescence intensity was detected 3 h after treatment using a 
Biotek Synergy HT Microplate Plate Reader with 485 nm emission and 530 nm excitation 
wavelengths. 
3.5. On-Chip Flow Cytometry 
The cells were treated as described above and cultured for 24 and 48 h. After incubation, the cells 
were trypsinized, collected, stained with Anexinn V-biotin Apoptosis Detection kit (Calbiochem) and 
Calcein AM (Invitrogen) and quantified by on-chip flow-cytometry. The number of apoptotic cells was 
assessed with Agilent Lab-on-a-chip Bioanalyzer 2100, as percent of apoptotic cells in live cells. 
4. Conclusions  
The antiproliferative and proapoptotic effects of the flavan-3-ols and GA are dose and time-
dependent. The galloylated catechins showed stronger effects than those of non-galloylated structures. 
The galloyl moiety appears to be required both for the antiproliferative, apoptotic and antioxidant effects, 
but there is no clear structure-activity relationship. In conclusion, the results of this study indicate that, Int. J. Mol. Sci. 2011, 12                    
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from all the dietary flavan-3-ols studied, EGCG is the most efficient in the Hs578T breast cancer cell 
line. EGCG, EGC or GA are able to induce an inhibition of cell proliferation and to modulate apoptosis. 
Flavan-3-ols may have a dual function, both  as antioxidants and pro-oxidants,  depending on  their 
concentration and exposure time on the cell culture. 
Further studies in this area are needed to determine if catechins or their metabolites are primarily 
responsible for the health benefits of flavan-3-ols. Moreover, future studies should be based on the 
investigation of the precise molecular action mechanisms of flavan-3-ols and GA in Hs578T cells. 
These studies will bring new data on future therapeutic applications and chemopreventive effects in 
triple negative breast cancer. 
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